Subashnie Devkaran, PhD, chair of quality and value at Rochester, Minn.-based Mayo Clinic, is joining the Joint Commission Enterprise Nov. 2 as executive vice president and chief international officer.
In this role, Dr. Devkaran will lead the Joint Commission’s international strategy and work to advance patient safety and quality around the world. She has worked with the accreditation organization for years, including nine as an internal consultant and a board member for three. The Joint Commission announced the appointment Oct. 28.
Dr. Devkaran has previously served Cleveland Clinic as director of accreditation, risk and performance improvement for Cleveland Clinic Abu Dhabi, United Arab Emirates, and director of accreditation, enterprise quality and safety for the system. According to her LinkedIn profile, she joined Mayo Clinic in 2022 as chair of quality and value, where she oversees the Kern Center for the Science of Healthcare Delivery.
The Joint Commission has announced several leadership transition plans recently, including the retirement of its president and CEO, Jonathan Perlin, MD, PhD. In January, James Merlino, MD, executive vice president and COO, will take the top post, and Ken Grubbs, DNP, RN, chief nurse executive and executive vice president of accreditation and certification operations, will add COO to his list of roles.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
